Radiotherapy and Inflammation in Prostate Cancer
Author Information
Author(s): Paal Katarzyna, Stranz Bettina, Thurner Eva-Maria, Niedrist Tobias, Renner Wilfried, Langsenlehner Tanja
Primary Institution: Medical University of Graz
Hypothesis
Does prostate cancer radiotherapy influence systemic inflammation and contribute to aging-related conditions?
Conclusion
Radiation therapy triggers chronic inflammatory processes that may worsen age-related conditions.
Supporting Evidence
- Radiotherapy significantly increased levels of inflammatory markers like fibrinogen and NLR.
- Cholesterol and albumin levels decreased during treatment but showed some recovery afterward.
- Fibrinogen levels remained elevated 15 months post-treatment compared to baseline.
Takeaway
This study found that radiation treatment for prostate cancer can cause inflammation, which might make aging-related health issues worse.
Methodology
The study analyzed inflammatory blood parameters in 306 prostate cancer patients before, during, and after radiotherapy.
Limitations
The study lacked a control group for comparison with non-irradiated individuals.
Participant Demographics
Median age was 73 years, with a majority aged 65 and older.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website